Bpth stock price history
Bpth price history, BPTH All time chart with daily, weekly, monthly prices and market capitalizations BPTH - Bio-Path Holdings Stock Price - Barchart.com It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. Bio-Path Holdings, Inc. bio-path holdings announces successful completion of safety testing in stage 2 of phase 2 clinical trial in acute myeloid leukemianov 26 2019. bio-path holdings announces clearance of investigational new drug application for bp1002nov 21 2019. bio-path holdings reports third quarter 2019 financial resultsnov 15 … BPTH Market Cap History
Records 1 - 18 of 21 Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2019, EDGAR®Online, a division of Donnelley
All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be Get today's Bio Path Holdings Inc stock price and latest BPTH news as well as Bio Path real-time stock quotes, technical analysis, full financials and more. Technical Analysis for BPTH - Bio-Path Holdings Inc. Quote; Chart; Signals; Profile; Buy or Sell? News & Commentary; Indicators; Fundamentals Stock analysis for Bio-Path Holdings Inc (BPTH:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company Bpth Stock Chart and Share Price Forecast, Short-Term "BPTH" Stock Prediction for Next Days Bio-Path Holdings Provides Clinical Update and 2020 Business OutlookJan 8 2020. H.C. Wainwright / BPTH: Safety Testing of Phase 2 AML Trial Completed;
Mar 8, 2019 BPTH (Bio Path Holdings Inc) had a Press . use technical analysis and chart patterns to find low risk, high reward stock trading opportunities.
Find the latest Bio-Path Holdings, Inc. (BPTH) stock quote, history, news and other vital information to help you with your stock trading and investing. BPTH Split History Bio-Path Holdings (BPTH) has 2 splits in our BPTH split history database. The first split for BPTH took place on February 09, 2018. This was a 1 for 10 reverse split, meaning for each 10 shares of BPTH owned pre-split, the shareholder now owned 1 share. BPTH | Bio-Path Holdings Inc. Stock Price & News - WSJ View the latest Bio-Path Holdings Inc. (BPTH) stock price, news, historical charts, analyst ratings and financial information from WSJ. BPTH Stock Price and Chart — NASDAQ:BPTH — TradingView View live BIO-PATH HOLDINGS INC chart to track its stock's price action. Find market predictions, BPTH financials and market news.
Records 1 - 18 of 21 Get up to 10 years of daily historical stock prices & volumes. Data provided by Edgar Online. ©2019, EDGAR®Online, a division of Donnelley
According to our BPTH split history records, Bio-Path Holdings has had 2 splits. Dividend Channel S.A.F.E. 25. To make the "Dividend Channel S.A.F.E. 25" a stock Mar 22, 2020 Real-time trade and investing ideas on Bio-Path Holdings Inc. BPTH from the largest community of traders and investors. Our flagship email guides investors to the most important, insightful items required to chart the trading day ahead. Critical Information Ahead of the U.S. Trading Bio-Path Holdings stocks price quote with latest real-time prices, charts, financials, Full Chart. Realtime quote and/or trades are not sourced from all markets. Stock quote and company snapshot for BIO PATH HOLDINGS INC (BPTH), including profile, stock chart, recent news and events, analyst opinions, and research View Bio-Path Holdings, Inc. BPTH investment & stock information. Get the latest Bio-Path Holdings, Inc. BPTH detailed stock quotes, stock data, Real-Time ECN
BPTH Stock Price and Chart — NASDAQ:BPTH — TradingView — …
Jan 18, 2019 · Bio-Path Holdings, Inc. is a biotechnology company, which engages in the develpment of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline include Prexigebersen, BP1002, and BP1003. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in … Bio Path Stock Quote. BPTH - Stock Price, News, Charts ... Latest stock price today and the US's most active stock market forums. Bio Path (BPTH) stock price, charts, trades & the US's most popular discussion forums. Free … BPTH - Stock quote for BIO-PATH HOLDINGS, INC. - MSN Money
Mar 27, 2020 · Bio-Path Holdings, Inc. (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the full year ended December 31, 2019 and provided an update on recent corporate developments. Bio-Path Holdings, Inc. (BPTH) Stock Price, Quote, History ... Bio-Path Holdings, Inc., (BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial results for the full year ended December 31, 2019 and provided an update on recent corporate developments.